CEFALY Technology, founded in 2008, is dedicated to revolutionizing migraine care through innovative, drug-free, and non-invasive therapeutic solutions. The company aims to address the ongoing challenges of migraine management with advanced neuro-therapeutic technology. Their flagship product, the CEFALY DUAL, is an external Trigeminal Nerve Stimulator that provides controlled electrical impulses to help reduce the frequency and intensity of migraine attacks. In 2020, CEFALY DUAL became the first device of its kind available over-the-counter in the United States, and the company has since treated over 2 billion migraines globally, striving to expand access to effective migraine care.